The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...
In a study published in Cell Stem Cell, scientists tested retinal pigment epithelial stem cells in a phase 1/2a clinical trial. The cells were obtained from adult postmortem eye tissue. These ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes ...
24/7 Wall St. on MSN
Trump’s Tariffs Led These 2 Companies To Invest Billions in The US
President Trump's reciprocal tariffs have led to unprecedented trillions in foreign investments into US manufacturing.
Scientists have discovered why males get dental disease more frequently and with greater severity than females, pinpointing ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases.
2hon MSN
Off-label use of COVID-19 vaccines was once discouraged but has become common amid new guidelines
Following the federal government's changes to COVID-19 vaccine eligibility and recommendations in 2025, many people are ...
7hon MSN
Most people are happy to do their own hearing tests at home. Could it relieve pressure on the NHS?
Beyond relieving pressure on existing NHS services, home testing could offer patients greater choice, more convenience, ...
In this video from the American Academy of Ophthalmology meeting, Michael W. Stewart, MD, discusses 3-year data from the GALE study on geographic atrophy treatment with pegcetacoplan.
A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback